| Development of self-microemulsifying drug delivery system for oral delivery of poorly water-soluble nutraceuticals AV Shah, HH Desai, P Thool, D Dalrymple, ATM Serajuddin Drug development and industrial pharmacy 44 (6), 895-901, 2018 | 39 | 2018 |
| Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders–Part I S Meruva, P Thool, S Shah, S Karki, W Bowen, I Ghosh, S Kumar International Journal of Pharmaceutics 568, 118189, 2019 | 32 | 2019 |
| Decoding the small size challenges of mini-tablets for enhanced dose flexibility and micro-dosing B Mitra, P Thool, S Meruva, JA Aycinena, J Li, J Patel, K Patel, A Agarwal, ... International Journal of Pharmaceutics 574, 118905, 2020 | 30 | 2020 |
| Effect of different polysorbates on development of self-microemulsifying drug delivery systems using medium chain lipids A Shah, P Thool, K Sorathiya, H Prajapati, D Dalrymple, ATM Serajuddin Drug development and industrial pharmacy 44 (2), 215-223, 2018 | 23 | 2018 |
| Development of low dose micro-tablets by high shear wet granulation process S Gupta, P Thool, S Meruva, J Li, J Patel, A Agrawal, S Karki, W Bowen, ... International Journal of Pharmaceutics 587, 119571, 2020 | 19 | 2020 |
| Downstream processing of irbesartan nanocrystalline suspension and mini-tablet development–Part II S Meruva, P Thool, S Karki, W Bowen, I Ghosh, S Kumar International Journal of Pharmaceutics 568, 118509, 2019 | 13 | 2019 |
| Use of drug release testing to evaluate the retention of abuse-deterrent properties of polyethylene oxide matrix tablets S Meruva, L Rezaei, P Thool, MD Donovan AAPS PharmSciTech 21, 1-12, 2020 | 10 | 2020 |
| Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets S Meruva, P Thool, Y Gong, S Karki, W Bowen, S Kumar International Journal of Pharmaceutics 577, 119026, 2020 | 9 | 2020 |
| A novel use of nanocrystalline suspensions to develop sub-microgram dose micro-tablets S Meruva, P Thool, Y Gong, A Agrawal, S Karki, W Bowen, B Mitra, ... Journal of Pharmaceutical Sciences 110 (9), 3276-3288, 2021 | 6 | 2021 |
| Development of a Near-Infrared Spectroscopy (NIRS)–Based Characterization Approach for Inherent Powder Blend Heterogeneity in Direct Compression Formulations Z Shi, KS Rao, P Thool, R Kuhn, R Thomas, S Rich, C Mao The AAPS Journal 25 (1), 9, 2022 | 1 | 2022 |
| Pharmaceutical compositions comprising (s)-4-(4-(4-(((2-(2, 6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl) oxy) methyl) benzyl) piperazin-1-yl)-3-fluorobenzonitrile and methods … A Agrawal, MJ Chen, SB Karki, PG Thool, D Visky, R Xie US Patent App. 18/240,076, 2024 | | 2024 |
| Pharmaceutical compositions comprising (s)-4-(4-(4-(((2-(2, 6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl) oxy) methyl) benzyl) piperazin-1-yl)-3-fluorobenzonitrtle and methods … A Agrawal, MJ Chen, SB Karki, PG Thool, D Visky, R Xie US Patent 11,779,580, 2023 | | 2023 |
| Pharmaceutical compositions comprising (s)-4-(4-(4-(((2-(2, 6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl) oxy) methyl) benzyl) piperazin-1-yl)-3-fluorobenzonitrile and methods … A Agrawal, BK Mitra, PG Thool, S Higgins-gruber, JA Rodriguez, D Liu US Patent App. 18/014,882, 2023 | | 2023 |
| Evaluation of Time Consolidation Effect of Pharmaceutical Powders P Thool, C Stancill, M Bui, C Mao Pharmaceutical Research 39 (12), 3345-3357, 2022 | | 2022 |
Saikishore MeruvaBristol Myers SquibbVerified email at bms.com
